Foetal haemoglobin inducers for reducing blood transfusion in non-transfusion-dependent beta-thalassaemias
Author:
Affiliation:
1. Department of Paediatrics; RCSI & UCD Malaysia Campus (formerly Penang Medical College); George Town Malaysia
2. Department of Paediatrics; Universiti Kebangsaan Malaysia Medical Centre; 56000 Cheras Malaysia
Publisher
Wiley
Subject
Pharmacology (medical)
Reference135 articles.
1. Optimizing the dose of hydroxyurea in thalassemia intermedia;Bohara;Indian Journal Hematology Blood Transfusion,2012
2. Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E- β-thalassemia): a single center study from Eastern India;Bohara;Hemoglobin,2014
3. HQK-1001 is well tolerated and augments hemoglobin F and hemoglobin levels in patients with beta thalassemia intermedia;Fuchareon;Blood,2010
4. A randomized phase I/II trial of HQK-1001, an oral fetal globin gene inducer, in β-thalassaemia intermedia and HbE/β-thalassaemia;Fucharoen;British Journal of Haematology,2013
5. Comparison of the efficacy and safety of herbal product (Resveratrol) with hydroxyurea (HU) in non- transfusion- dependent B-thalassemia intermedia en.irct.ir/trial/17784
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3